Effect of metformin on cardiovascular risk factors in middle-aged Thai women with metabolic syndrome: A randomized placebo-controlled trial.
Suchada IndhavivadhanaManee RattanachaiyanontThanyarat WongwananurakKitirat TechatraisakApiradee JirattigalachoteChongdee DangratPublished in: The journal of obstetrics and gynaecology research (2020)
Metformin can improve some parameters of metabolic syndrome in middle-aged Thai women. Metformin is not superior to placebo for the improvement of cardiovascular risk factors.